ARS PHARMACEUTICALS INC (SPRY) Institutional Shareholders

ARS PHARMACEUTICALS INC (SPRY) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $715.86M in SPRY holdings during the latest filing period.

Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of SPRY tracked by InsiderSet, reporting ownership valued at approximately $87.00M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $45.07M, representing an estimated loss of -48.19% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 67% of the total disclosed SPRY value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Rubric Capital Management Lp, Orbimed Advisors Llc, and several other long-term asset managers with concentrated positions in ARS PHARMACEUTICALS INC (SPRY).

This page ranks the largest institutional SPRY shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

202

Total Reported Value

$715.86M

Largest Holder

Ra Capital Management, L.P.

Largest Position

$87.00M

Insider Transactions (90d)

0

Latest Filing Quarter

Q2 2026

New Institutional Positions

69

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Ra Capital Management, L.P.0.76%10,860,977$86,996,426$45,073,055-$41,923,371-48.19%
Rubric Capital Management Lp0.63%8,540,861$68,412,297$35,444,573-$32,967,724-48.19%
Orbimed Advisors Llc1.26%8,288,510$66,390,965$34,397,317-$31,993,649-48.19%
Deerfield Management Company, L.P.0.63%7,503,812$60,105,534$31,140,820-$28,964,714-48.19%
Blackrock, Inc.0.00%5,311,319$42,543,666$22,041,974-$20,501,692-48.19%
Tyro Capital Management Llc8.01%4,459,337$35,719,289$18,506,249-$17,213,040-48.19%
Aberdeen Group Plc0.05%4,170,629$33,406,738$17,308,110-$16,098,628-48.19%
Sr One Capital Management, Lp3.09%4,012,903$32,143,353$16,653,547-$15,489,806-48.19%
State Street Corp0.00%3,730,623$29,882,290$15,482,085-$14,400,205-48.19%
Capital World Investors0.00%2,754,931$22,066,997$11,432,964-$10,634,033-48.19%
Vanguard Capital Management Llc0.00%2,553,528$20,453,759$10,597,141-$9,856,618-48.19%
Millennium Management Llc0.01%2,400,937$19,231,505$9,963,889-$9,267,616-48.19%
Janney Montgomery Scott Llc0.03%2,064,498$16,537,000$8,567,667-$7,969,333-48.19%
Ubs Group Ag0.00%1,939,654$15,536,629$8,049,564-$7,487,065-48.19%
Geode Capital Management, Llc0.00%1,699,017$13,612,279$7,050,921-$6,561,358-48.20%
Boothbay Fund Management, Llc0.24%1,601,504$12,828,047$6,646,242-$6,181,805-48.19%
General American Investors Co Inc0.55%1,133,046$9,075,698$4,702,141-$4,373,557-48.19%
Third PointDaniel Loeb0.17%1,000,000$8,010,000$4,150,000-$3,860,000-48.19%
Peregrine Capital Management Llc0.17%672,139$5,383,833$2,789,377-$2,594,456-48.19%
Tejara Capital Ltd2.00%607,039$4,862,382$2,519,212-$2,343,170-48.19%
Adar1 Capital Management, Llc0.23%600,999$4,814,002$2,494,146-$2,319,856-48.19%
Vanguard Portfolio Management Llc0.00%566,829$4,540,300$2,352,340-$2,187,960-48.19%
Charles Schwab Investment Management Inc0.00%551,416$4,416,842$2,288,376-$2,128,466-48.19%
Northern Trust Corp0.00%549,064$4,398,003$2,278,616-$2,119,387-48.19%
Citadel Advisors Llc0.00%531,063$4,253,814$2,203,911-$2,049,903-48.19%
Empire Life Investments Inc.0.21%471,856$3,779,567$1,958,202-$1,821,365-48.19%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.00%464,681$3,731,388$1,928,426-$1,802,962-48.32%
Bank Of America Corp0.00%463,256$3,710,681$1,922,512-$1,788,169-48.19%
Vanguard Fiduciary Trust Co0.00%461,001$3,692,618$1,913,154-$1,779,464-48.19%
Fil Ltd0.00%455,575$3,649,156$1,890,636-$1,758,520-48.19%
Jpmorgan Chase & Co0.00%363,316$3,109,986$1,507,761-$1,602,225-51.52%
Goldman Sachs Group Inc0.00%380,770$3,049,967$1,580,196-$1,469,771-48.19%
Eversept Partners, Lp0.16%377,007$3,019,826$1,564,579-$1,455,247-48.19%
K2 Principal Fund, L.P.0.28%375,132$3,004,807$1,556,798-$1,448,009-48.19%
Investment Management Associates Inc0.76%373,491$2,991,663$1,549,988-$1,441,675-48.19%
Fmr Llc0.00%349,164$2,796,806$1,449,031-$1,347,775-48.19%
Raymond James Financial Inc0.00%318,583$2,551,850$1,322,119-$1,229,731-48.19%
Trexquant Investment Lp0.01%286,733$2,296,731$1,189,942-$1,106,789-48.19%
Jump Financial, Llc0.02%255,200$2,044,152$1,059,080-$985,072-48.19%
Morgan Stanley0.00%229,100$1,835,091$950,765-$884,326-48.19%
Fas Wealth Partners, Inc.0.09%214,507$1,718,202$890,204-$827,998-48.19%
Hennion & Walsh Asset Management, Inc.0.04%175,614$1,406,668$728,798-$677,870-48.19%
Quinn Opportunity Partners Llc0.07%175,000$1,401,750$726,250-$675,500-48.19%
Bank Of New York Mellon Corp0.00%168,136$1,346,769$697,764-$649,005-48.19%
Dafna Capital Management Llc0.25%164,285$1,315,923$681,783-$634,140-48.19%
Nuveen, Llc0.00%161,342$1,292,350$669,569-$622,781-48.19%
Ishara Investments Lp0.84%143,490$1,149,355$595,484-$553,872-48.19%
Engineers Gate Manager Lp0.01%139,419$1,116,746$578,589-$538,157-48.19%
Steward Partners Investment Advisory, Llc0.01%128,600$1,030,086$533,690-$496,396-48.19%
Barclays Plc0.00%126,261$1,011,352$523,983-$487,369-48.19%
Showing 50 of 202

Frequently asked questions about SPRY

  • Who owns the most SPRY stock?

    The largest holders of SPRY are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ARS PHARMACEUTICALS INC (SPRY).

  • Is SPRY widely held by superinvestors?

    Many widely followed stocks like SPRY appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly SPRY is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.